These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Genetic regulation of hypergammaglobulinaemia and the correlation to autoimmune traits in (NZB X NZW) F1 hybrid. Hirose S; Sekigawa I; Ozaki S; Sato H; Shirai T Clin Exp Immunol; 1984 Dec; 58(3):694-702. PubMed ID: 6334582 [TBL] [Abstract][Full Text] [Related]
27. Regulation of azophenylarsonate-specific repertoire expression. II. Fine specificity and isotype heterogeneity of anti-arsonate antibodies. Sigal NH J Immunol; 1983 Oct; 131(4):1889-94. PubMed ID: 6194218 [TBL] [Abstract][Full Text] [Related]
28. The immunogenicity of soluble haptenated polymers is determined by molecular mass and hapten valence. Dintzis RZ; Okajima M; Middleton MH; Greene G; Dintzis HM J Immunol; 1989 Aug; 143(4):1239-44. PubMed ID: 2473123 [TBL] [Abstract][Full Text] [Related]
29. Toxoplasma gondii infection inhibits the development of lupus-like syndrome in autoimmune (New Zealand Black x New Zealand White) F1 mice. Chen M; Aosai F; Norose K; Mun HS; Ishikura H; Hirose S; Piao LX; Fang H; Yano A Int Immunol; 2004 Jul; 16(7):937-46. PubMed ID: 15148287 [TBL] [Abstract][Full Text] [Related]
30. Identification of recurrent idiotypes within the unrestricted anti-fluorescein immune response. Reinitz DM; Voss EW J Immunol; 1985 Nov; 135(5):3365-71. PubMed ID: 2413119 [TBL] [Abstract][Full Text] [Related]
31. A public idiotypic determinant is present on spontaneous cationic IgG antibodies to DNA from mice of unrelated lupus-prone strains. Hahn BH; Ebling FM J Immunol; 1984 Dec; 133(6):3015-9. PubMed ID: 6208269 [TBL] [Abstract][Full Text] [Related]
32. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse. Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055 [TBL] [Abstract][Full Text] [Related]
33. Relative binding properties of fluorescein and 9-hydroxyphenylfluoron (HPF) with murine monoclonal anti-fluorescein antibodies. Bedzyk WD; Swindlehurst CA; Voss EW Biochim Biophys Acta; 1992 Feb; 1119(1):27-34. PubMed ID: 1540631 [TBL] [Abstract][Full Text] [Related]
34. Analysis of the monocyte Fc receptors and antibody-mediated cellular interactions required for the induction of T cell proliferation by anti-T3 antibodies. Clement LT; Tilden AB; Dunlap NE J Immunol; 1985 Jul; 135(1):165-71. PubMed ID: 3923099 [TBL] [Abstract][Full Text] [Related]
35. Defective antigen-receptor-mediated regulation of immunoglobulin production in B cells from autoimmune strains of mice. Anderson CC; Cairns E; Rudofsky UH; Sinclair NR Cell Immunol; 1995 Aug; 164(1):141-9. PubMed ID: 7634346 [TBL] [Abstract][Full Text] [Related]
36. A mouse IgM allotypic determinant (Igh-6.5) recognized by a monoclonal rat antibody. Kung JT; Sharrow SO; Sieckmann DG; Lieberman R; Paul WE J Immunol; 1981 Sep; 127(3):873-6. PubMed ID: 6167630 [TBL] [Abstract][Full Text] [Related]
37. Monoclonal antibodies to streptococcal group A carbohydrate. II. The VK1GAC light chain is preferentially associated with serum IgG3. Fulton RJ; Nahm MH; Davie JM J Immunol; 1983 Sep; 131(3):1326-31. PubMed ID: 6411813 [TBL] [Abstract][Full Text] [Related]
38. Identification of peptide mimotopes for the fluorescein hapten binding of monoclonal antibody B13-DE1. Böttger V; Peters L; Micheel B J Mol Recognit; 1999; 12(3):191-7. PubMed ID: 10398409 [TBL] [Abstract][Full Text] [Related]
39. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32). Werwitzke S; Trick D; Sondermann P; Kamino K; Schlegelberger B; Kniesch K; Tiede A; Jacob U; Schmidt RE; Witte T Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887 [TBL] [Abstract][Full Text] [Related]
40. Male New Zealand Black/KN mice: a novel model for autoimmune-induced permanent alopecia? Hiroi A; Ito T; Seo N; Uede K; Yoshimasu T; Ito M; Nakamura K; Ito N; Paus R; Furukawa F Br J Dermatol; 2006 Aug; 155(2):437-45. PubMed ID: 16882186 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]